Glenmark Pharma launches Akynzeo IV in India

Glenmark Pharma launches Akynzeo IV in India

by admin- Monday, January 23rd, 2023 03:30:25 PM

 

Glenmark Pharmaceuticals Ltd is the first to release in India a completely unique IV injection formula, AKYNZEO

IV, for the prevention of chemotherapy-brought about nausea and vomiting (CINV), under an distinct licensing settlement with Helsinn, a Swiss biopharma organization employer.

News Updates